Status:
RECRUITING
Detection of Spinal Cord Lesions Using the MP2RAGE Sequence in Inflammatory Diseases of the Neuraxis
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Since the last revision of the MRI guidelines in multiple sclerosis (MS, MAGNIMS) and the McDonald criteria in 2017, all spinal cord lesions must be counted to increase the sensitivity and specificity...
Eligibility Criteria
Inclusion
- Patient aged over 18 years
- scheduled to undergo 1.5T or 3T MRI of the spinal cord as part of an initial assessment or reassessment of inflammatory neuraxial disease.
- Express consent to participate in the study
- Member or beneficiary of a social security scheme
Exclusion
- Patient benefiting from a legal protection measure
- Pregnant women
- Absolute or relative contraindication to 1.5T or 3T MRI
Key Trial Info
Start Date :
July 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT06589999
Start Date
July 31 2024
End Date
July 1 2026
Last Update
January 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Fondation Adolphe de Rothschild
Paris, France